UNH

Unitedhealth Group
D

UNH

Arincen63/100B
409.28
USD
5.31
(1.31%)
Post Trading·411.20USD+1.92(+0.47%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.28Revenue estimate 112.26B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Unitedhealth Group cash on hand 1985–2026

Unitedhealth Group had 28.55B USD in cash and short-term investments on 30 September 2026, down 6.7% on a year before. At the end of fiscal year 2025 it had 28.12B USD.

Last updated 4 Nov 2026 · Next report 20 Jan 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 202628.55B-6.75%74.33B-45.78B
FY202531 Dec 202528.12B-3.41%78.39B-50.27B
FY202431 Dec 202429.11B-1.74%76.90B-47.79B
FY202331 Dec 202329.63B+6.15%67.44B-37.81B
FY202231 Dec 202227.91B+16.75%57.62B-29.71B
FY202131 Dec 202123.91B+20.86%46.00B-22.10B
FY202031 Dec 202019.78B+38.86%43.47B-23.69B
FY201931 Dec 201914.25B-0.55%40.68B-26.43B
FY201831 Dec 201814.32B-7.53%36.55B-22.23B
FY201731 Dec 201715.49B+16.69%31.69B-16.20B
FY201631 Dec 201613.28B+2.82%32.97B-19.70B
FY201531 Dec 201512.91B+39.79%32.09B-19.18B
FY201431 Dec 20149.24B+0.25%17.41B-8.17B
FY201331 Dec 20139.21B-19.45%16.86B-7.65B
FY201231 Dec 201211.44B-4.74%16.75B-5.32B
FY201131 Dec 201112.01B+7.24%11.64B368.00M
FY201031 Dec 201011.20B+1.41%11.14B53.00M
FY200931 Dec 200911.04B+34.47%11.17B-134.00M
FY200831 Dec 20088.21B-14.66%12.79B-4.59B
FY200731 Dec 20079.62B-12.07%11.01B-1.39B
FY200631 Dec 200610.94B+82.00%7.46B3.48B
FY200531 Dec 20056.01B+33.43%7.11B-1.10B
FY200431 Dec 20044.51B+63.94%4.02B482.00M
FY200331 Dec 20032.75B+50.08%1.98B769.00M
FY200231 Dec 20021.83B+1.16%1.76B70.00M
FY200131 Dec 20011.81B+11.80%1.58B226.00M
FY200031 Dec 20001.62B-24.73%1.21B410.00M
FY199931 Dec 19992.15B+18.58%991.00M1.16B
FY199831 Dec 19981.81B+44.43%708.00M1.11B
FY199731 Dec 19971.26B-23.75%19.00M1.24B
FY199631 Dec 19961.65B-8.68%30.76M1.62B
FY199531 Dec 19951.80B+9.04%38.97M1.76B
FY199431 Dec 19941.65B+1,030.01%24.28M1.63B
FY199331 Dec 1993146.40M+13.75%700.00K145.70M
FY199231 Dec 1992128.70M-6.74%400.00K128.30M
FY199131 Dec 1991138.00M+156.03%3.40M134.60M
FY199031 Dec 199053.90M-15.38%7.00M46.90M
FY198931 Dec 198963.70M-33.02%58.30M5.40M
FY198831 Dec 198895.10M+55.65%60.00M35.10M
FY198731 Dec 198761.10M+25.98%62.80M-1.70M
FY198631 Dec 198648.50M+183.63%52.90M-4.40M
FY198531 Dec 198517.10M—0.0017.10M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Unitedhealth Group's cash

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.